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Drug-loaded nanoparticles for spinal cord injury regeneration 
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Unlike fish, amphibia and even mammalial peripheral nerves, human central nervous 
system (CNS) axons have a very limited regeneration capability and do not 
spontaneously re-grow if lesioned. After damage or disruption, for instance caused by  
brain/ spinal cord injury (SCI) or stroke, a cascade of cellular and biochemical reactions 
occurs around the lesion site that creates a harsh environment for axons to regenerate. 
Immune and glial cells around the injury are also responsible for the production of 
molecules that restrain the axon re-growth, such as myelin associated inhibitors and 
chondroitin sulfate proteoglycans. Additionally, astrocytes and fibroblasts contribute to 
the formation of a scar around the damaged tissue that physically blocks axon repair. 
Thus, and in view of the latest findings it is imperative to block these inhibitory 
reactions and induce a more adequate environment for tissue repair and regeneration. 
In our lab, we are currently developing biomaterial-based strategies to repair the injured 
CNS, focusing on spinal cord. The absence of effective therapies in SCI repair is in part 
due to its extreme complexity, but also to the lack of efficiency and targeting of the 
existing drugs. In order to target the detrimental cellular responses that follow the injury 
in a more specific and sustained manner, we developed a nanoparticle-based drug 
delivery system intended to target glial cells and modulate the inflammatory processes 
in SCI. Poly/(amido)amine (PAMAM) dendrimer nanoparticles grafted with 
carboxymethylchitosan (CMCht) were loaded with the anti-inflammatory corticosteroid 
methylprednisolone. The nanoparticles were shown to be internalized by glial cells 
without affecting its metabolic viability, while releasing the drug in a sustained and 
prolonged manner. Nanoparticle administration in spinal cord injured rats induced 
improved recovery in these animals, suggesting that nanoparticles can limit the damage 
extent and contribute to nerve repair/ sparing. 
We believe that strategies such as this, intending to minimize the secondary events that 
follow nervous injury can be an opportunity for successful treatments in CNS tissue 
repair.  
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